TRC Capital

Amrize Ltd (AMRZ) advises shareholders to reject TRC Capital’s unsolicited mini-tender offer to purchase up to 2,000,000 shares at $49.63 each. This offer is below Amrize’s August 26 closing price of $51.96 and is contingent on conditions, including a 5% share price decline limit. Amrize cautions that tendering shares at the proposed price would be disadvantageous and urges shareholders to consult financial advisors. Shareholders who tendered can withdraw before September 25.